Works in Cancer Immunology, Immunotherapy, 2025, Vol 74, Issue 2
Results: 36
Correction: Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
IDO1 inhibitor enhances the effectiveness of PD-1 blockade in microsatellite stable colorectal cancer by promoting macrophage pro-inflammatory phenotype polarization.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03925-w
- By:
- Publication type:
- Article
CircRNA-loaded DC vaccine in combination with low-dose gemcitabine induced potent anti-tumor immunity in pancreatic cancer model.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03924-x
- By:
- Publication type:
- Article
Therapeutic potential of anti-ErbB3 chimeric antigen receptor natural killer cells against breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03923-y
- By:
- Publication type:
- Article
TDO2 + cancer-associated fibroblasts mediate cutaneous squamous cell carcinoma immune escape via impeding infiltration of CD8 + T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03921-0
- By:
- Publication type:
- Article
Unsupervised clustering reveals noncanonical myeloid cell subsets in the brain tumor microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03920-1
- By:
- Publication type:
- Article
Understanding the impact of spatial immunophenotypes on the survival of endometrial cancer patients through the ProMisE classification.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03919-8
- By:
- Publication type:
- Article
Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03917-w
- By:
- Publication type:
- Article
Tumor-colonizing Lachnoclostridium-mediated chemokine expression enhances the immune infiltration of bladder urothelial carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03916-x
- By:
- Publication type:
- Article
STC1 encapsulated in small extracellular vesicles from laryngeal squamous cell carcinoma cells induces CD8<sup>+</sup> T cell dysfunction by reprogramming tumor-associated macrophages into M2-like macrophages.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03915-y
- By:
- Publication type:
- Article
Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03911-2
- By:
- Publication type:
- Article
CCR5 and IL-12 co-expression in CAR T cells improves antitumor efficacy by reprogramming tumor microenvironment in solid tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03909-w
- By:
- Publication type:
- Article
Identification of immune suppressor candidates utilizing comparative transcriptional profiling in histiocytic sarcoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03908-x
- By:
- Publication type:
- Article
Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human disease.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03907-y
- By:
- Publication type:
- Article
Efficacy and safety of PD-1 blockade-activated neoantigen specific cellular therapy for advanced relapsed non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03906-z
- By:
- Publication type:
- Article
Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167).
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03905-0
- By:
- Publication type:
- Article
Distinct immune signatures for predicting the immunotherapy efficacy of esophageal squamous cell carcinoma or adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03904-1
- By:
- Publication type:
- Article
Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03903-2
- By:
- Publication type:
- Article
Cytokine profile of bronchoalveolar lavage in patients with and without checkpoint inhibitor pneumonitis.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03902-3
- By:
- Publication type:
- Article
Anti-PD1-/PDL1-induced chronic intestinal pseudo-obstruction: three cases treated with vedolizumab after corticosteroid failure with mixed results.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Dual efficacy of tocilizumab in managing PD-1 inhibitors-induced myocardial inflammatory injury and suppressing tumor growth with PD-1 inhibitors: a preclinical study.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03899-9
- By:
- Publication type:
- Article
First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03897-x
- By:
- Publication type:
- Article
Spatial expression of fibroblast activation protein-α in clear cell renal cell carcinomas revealed by multiplex immunoprofiling analysis of the tumor microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03896-y
- By:
- Publication type:
- Article
Transferrin receptor uptakes iron from tumor-associated neutrophils to regulate invasion patterns of OSCC.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03894-0
- By:
- Publication type:
- Article
Therapeutic effect of fully human anti-Nrp-1 antibody on non–small cell lung cancer in vivo and in vitro.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03893-1
- By:
- Publication type:
- Article
Prognostic relevance of CD163<sup>+</sup> immune cells in patients with metastatic breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03892-2
- By:
- Publication type:
- Article
Prognostic immune markers in esophageal cancer patients managed with trimodal therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03891-3
- By:
- Publication type:
- Article
Efficacy and safety of nivolumab and ipilimumab with or without chemotherapy for unresectable non-small cell lung cancer: a multicenter retrospective observational study.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03890-4
- By:
- Publication type:
- Article
Fractionated low-dose radiotherapy primes the tumor microenvironment for immunotherapy in a murine mesothelioma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03889-x
- By:
- Publication type:
- Article
FcRn-guided antigen trafficking enhances cancer vaccine efficacy.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03888-y
- By:
- Publication type:
- Article
Role of the HGF/c-MET pathway in resistance to immune checkpoint inhibitors in advanced non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03882-4
- By:
- Publication type:
- Article
High CD38 expression defines a mitochondrial function-adapted CD8<sup>+</sup> T cell subset with implications for lung cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03881-5
- By:
- Publication type:
- Article
The correlation between LAG-3 expression and the efficacy of chemoimmunotherapy in advanced biliary tract cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03878-0
- By:
- Publication type:
- Article
Sex differences in immunotherapy outcomes and tumor-infiltrating immune cell profiles in patients with advanced renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03876-2
- By:
- Publication type:
- Article
CMV IgG in the blood is not associated with hepatitis but correlates with poor outcomes in immunotherapy treated melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03859-3
- By:
- Publication type:
- Article
Targeting immune checkpoints on myeloid cells: current status and future directions.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03856-6
- By:
- Publication type:
- Article